431 related articles for article (PubMed ID: 12613278)
1. Drug metabolism and pharmacokinetics in drug discovery.
Roberts SA
Curr Opin Drug Discov Devel; 2003 Jan; 6(1):66-80. PubMed ID: 12613278
[TBL] [Abstract][Full Text] [Related]
2. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.
Roberts SA
Xenobiotica; 2001; 31(8-9):557-89. PubMed ID: 11569526
[TBL] [Abstract][Full Text] [Related]
3. Utility of mass spectrometry for in-vitro ADME assays.
Chu I; Nomeir AA
Curr Drug Metab; 2006 Jun; 7(5):467-77. PubMed ID: 16787156
[TBL] [Abstract][Full Text] [Related]
4. Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development.
Baranczewski P; Stańczak A; Sundberg K; Svensson R; Wallin A; Jansson J; Garberg P; Postlind H
Pharmacol Rep; 2006; 58(4):453-72. PubMed ID: 16963792
[TBL] [Abstract][Full Text] [Related]
5. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
van de Waterbeemd H
Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
[TBL] [Abstract][Full Text] [Related]
6. In vitro methods in the prediction of kinetics of drugs: focus on drug metabolism.
Raunio H; Taavitsainen P; Honkakoski P; Juvonen R; Pelkonen O
Altern Lab Anim; 2004 Oct; 32(4):425-30. PubMed ID: 15651928
[TBL] [Abstract][Full Text] [Related]
7. PK/DB: database for pharmacokinetic properties and predictive in silico ADME models.
Moda TL; Torres LG; Carrara AE; Andricopulo AD
Bioinformatics; 2008 Oct; 24(19):2270-1. PubMed ID: 18684738
[TBL] [Abstract][Full Text] [Related]
8. Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics.
Smith DA; Jones BC; Walker DK
Med Res Rev; 1996 May; 16(3):243-66. PubMed ID: 8727426
[TBL] [Abstract][Full Text] [Related]
9. The emerging importance of predictive ADME simulation in drug discovery.
Selick HE; Beresford AP; Tarbit MH
Drug Discov Today; 2002 Jan; 7(2):109-16. PubMed ID: 11790621
[TBL] [Abstract][Full Text] [Related]
10. [The role of ADME evaluation in translation research of innovative drug].
Liu Y; Hong L; Yu LS; Jiang HD; Chen JZ; Meng Q; Chen SQ; Zeng S
Yao Xue Xue Bao; 2011 Jan; 46(1):19-29. PubMed ID: 21465804
[TBL] [Abstract][Full Text] [Related]
11. Improving compound quality through in vitro and in silico physicochemical profiling.
van de Waterbeemd H
Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
[TBL] [Abstract][Full Text] [Related]
12. In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International Consortium for Innovation through Quality in Pharmaceutical Development.
Lombardo F; Desai PV; Arimoto R; Desino KE; Fischer H; Keefer CE; Petersson C; Winiwarter S; Broccatelli F
J Med Chem; 2017 Nov; 60(22):9097-9113. PubMed ID: 28609624
[TBL] [Abstract][Full Text] [Related]
13. New horizons in drug metabolism, pharmacokinetics and drug discovery.
Palmer AM
Drug News Perspect; 2003; 16(1):57-62. PubMed ID: 12682673
[TBL] [Abstract][Full Text] [Related]
14. Predicting ADME properties and side effects: the BioPrint approach.
Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
[TBL] [Abstract][Full Text] [Related]
15. Can the Internet help to meet the challenges in ADME and e-ADME?
Van de Waterbeemd H; De Groot M
SAR QSAR Environ Res; 2002; 13(3-4):391-401. PubMed ID: 12184380
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
Honório KM; Moda TL; Andricopulo AD
Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
[TBL] [Abstract][Full Text] [Related]
17. Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical properties.
Mälkiä A; Murtomäki L; Urtti A; Kontturi K
Eur J Pharm Sci; 2004 Sep; 23(1):13-47. PubMed ID: 15324921
[TBL] [Abstract][Full Text] [Related]
18. Development of predictive pharmacokinetic simulation models for drug discovery.
Norris DA; Leesman GD; Sinko PJ; Grass GM
J Control Release; 2000 Mar; 65(1-2):55-62. PubMed ID: 10699270
[TBL] [Abstract][Full Text] [Related]
19. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
Masimirembwa CM; Bredberg U; Andersson TB
Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in physicochemical and ADMET profiling in drug discovery.
Wang J; Skolnik S
Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
